Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000125621 | SCV000169078 | benign | not specified | 2013-10-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Vantari Genetics | RCV000210810 | SCV000267095 | benign | Hereditary cancer-predisposing syndrome | 2016-01-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000125621 | SCV000303838 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV001095336 | SCV000478269 | benign | Tuberous sclerosis 1 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Eurofins Ntd Llc |
RCV000125621 | SCV000861485 | benign | not specified | 2018-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000125621 | SCV000966546 | likely benign | not specified | 2018-07-03 | criteria provided, single submitter | clinical testing | c.-7C>T in intron 2 of TSC1: This variant is classified as likely benign because a C>T/T>C change at this position does not diverge from the splice consensus se quence and is therefore unlikely to impact splicing. It has been identified in i n 0.1% (216/126578) of European chromosomes by the Genome Aggregation Database ( gnomAD, http://gnomad.broadinstitute.org; dbSNP rs62621221). ACMG/AMP Criteria a pplied: BP4, BP7, BS1_Supporting. |
Illumina Laboratory Services, |
RCV001167930 | SCV001330478 | benign | Isolated focal cortical dysplasia type II | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Institute for Clinical Genetics, |
RCV001530001 | SCV002009250 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001095336 | SCV002041174 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000125621 | SCV002072264 | benign | not specified | 2021-04-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001530001 | SCV002546111 | benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | TSC1: BS1, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000125621 | SCV002766020 | benign | not specified | 2022-11-03 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001095336 | SCV004015653 | benign | Tuberous sclerosis 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001095336 | SCV004360838 | benign | Tuberous sclerosis 1 | 2022-05-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001530001 | SCV005225994 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Tuberous sclerosis database |
RCV000054968 | SCV000083186 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
Diagnostic Laboratory, |
RCV001530001 | SCV001744458 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001530001 | SCV001921609 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000125621 | SCV001968456 | benign | not specified | no assertion criteria provided | clinical testing |